{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:37:27Z","timestamp":1793173047200,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1038\/sj.npp.1300021","type":"journal-article","created":{"date-parts":[[2003,2,20]],"date-time":"2003-02-20T18:06:51Z","timestamp":1045764411000},"page":"193-198","source":"Crossref","is-referenced-by-count":583,"title":["Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders"],"prefix":"10.1038","volume":"28","author":[{"given":"Eric","family":"Hollander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherie","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hanratty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona","family":"Yaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta M","family":"DeCaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie R","family":"Aronowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Mosovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,12,16]]},"reference":[{"key":"BF1300021_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0006-3223(98)00263-7","volume":"45","author":"M Altemus","year":"1999","unstructured":"Altemus M, Jacobson KR, Debellis M, Kling M, Pigott T, Murphy DL et al (1999). Normal CSF oxytocin and NPY levels in OCD. Biol. Psychiatry 45: 931\u2013933.","journal-title":"Biol. Psychiatry"},{"key":"BF1300021_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0306-4530(87)90009-6","volume":"12","author":"M Ansseau","year":"1987","unstructured":"Ansseau M, Legros JJ, Mormont C, Cerfontain JL, Papart P, Greenen V et al (1987). Intranasal oxytocin in obsessive\u2013compulsive disorder. Psychoneuroendocrinology 12: 231\u2013236.","journal-title":"Psychoneuroendocrinology"},{"key":"BF1300021_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jnr.490180209","volume":"18","author":"WA Banks","year":"1987","unstructured":"Banks WA, Kastin AJ, Horvath A, Michals EA (1987). Carrier-mediated transport of vasopressin across the blood\u2013brain barrier of the mouse. J Neurosci Res 18: 326\u2013332.","journal-title":"J Neurosci Res"},{"key":"BF1300021_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/0196-9781(84)90179-7","volume":"5","author":"R Brown","year":"1984","unstructured":"Brown R, King MG (1984). Arginine vasotocin and aggression in rats. Peptides 5: 1135\u20131138.","journal-title":"Peptides"},{"key":"BF1300021_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0014-2999(83)90449-1","volume":"94","author":"JPH Burbach","year":"1983","unstructured":"Burbach JPH, Bohus B, Kovacs GL, Van Nispen JW, Grven HM, de Wied D (1983a). Oxytocin is a precursor of potent behaviourally active neuropeptide. Eur J Pharmacol 94: 125\u2013131.","journal-title":"Eur J Pharmacol"},{"key":"BF1300021_CR6","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1126\/science.6351252","volume":"221","author":"JPH Burbach","year":"1983","unstructured":"Burbach JPH, Kovacs GL, de Wied D, Van Nispen JW, Greven HM (1983b). A major metabolite of arginine-vasopressin in the brain is a highly potent neuropeptide. Science 221: 1310\u20131312.","journal-title":"Science"},{"key":"BF1300021_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1749-6632.1992.tb34356.x","volume":"652","author":"CS Carter","year":"1992","unstructured":"Carter CS, Williams JR, Witt DM, Insel TR (1992). Oxytocin and social bonding. Ann NY Acad Sci 652: 204\u2013211.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300021_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(SICI)1098-2779(1998)4:2<113::AID-MRDD8>3.0.CO;2-Q","volume":"4","author":"EHJ Cook","year":"1998","unstructured":"Cook EHJ (1998). Genetics of autism. Mental Retardation Dev Disabil Res Rev 4: 113\u2013120.","journal-title":"Mental Retardation Dev Disabil Res Rev"},{"key":"BF1300021_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/0196-9781(92)90010-Z","volume":"13","author":"JA Den Boer","year":"1992","unstructured":"Den Boer JA, Westenberg HGM (1992). Oxytocin in obsessive compulsive disorder. Peptides 13: 1083\u20131085.","journal-title":"Peptides"},{"key":"BF1300021_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0024-3205(76)90165-X","volume":"19","author":"D de Wied","year":"1976","unstructured":"de Wied D (1976). Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments. Life Sci 19: 685\u2013690.","journal-title":"Life Sci"},{"key":"BF1300021_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1006\/frne.1993.1009","volume":"14","author":"D de Wied","year":"1993","unstructured":"de Wied D, Diamant M, Fodor M (1993). Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 14: 251\u2013302.","journal-title":"Front Neuroendocrinol"},{"key":"BF1300021_CR12","first-page":"268","volume":"241","author":"D de Wied","year":"1987","unstructured":"de Wied D, Gaffori O, Burbach JPH, Kavacs GL, van Ree JM (1987). Structure activity relationship studies with c-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J Pharmacol Exp Ther 241: 268\u2013274.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300021_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1476-5381.1972.tb09582.x","volume":"45","author":"D de Wied","year":"1972","unstructured":"de Wied D, Greven HM, Lande S, Witter A (1972). Dissociation of the behavioral and endocrine effects of lysine vasopressin by tryptic digestion. Br J Pharmacol 45: 118\u2013122.","journal-title":"Br J Pharmacol"},{"key":"BF1300021_CR14","first-page":"2348","volume":"38","author":"D de Wied","year":"1979","unstructured":"de Wied D, Versteeg DH (1979). Neurohypophyseal principles and memory. Fed Proc 38: 2348\u20132454.","journal-title":"Fed Proc"},{"key":"BF1300021_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0006-8993(86)90573-1","volume":"368","author":"F Drago","year":"1986","unstructured":"Drago F, Pedersen CA, Caldwell JD, Prange Jr AJ (1986). Oxytocin potently enhances novelty-induced grooming behavior in the rat. Brain Res 368: 287\u2013295.","journal-title":"Brain Res"},{"key":"BF1300021_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0006-3223(96)00120-5","volume":"40","author":"CN Epperson","year":"1996","unstructured":"Epperson CN, McDougle CJ, Price LH (1996). Intranasal oxytocin in obsessive\u2013compulsive disorder. Biol Psychiatry 40: 547\u2013549.","journal-title":"Biol Psychiatry"},{"key":"BF1300021_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-1-4684-5799-5_5","volume-title":"Circulating Regulatory Factors and Neuroendocrine Function","author":"A Ermisch","year":"1990","unstructured":"Ermisch A, Landgraf R (1990). Vasopressin\u2014blood\u2013brain barrier\u2014brain performance. Circulating Regulatory Factors and Neuroendocrine Function. Plenum Press: New York, pp 71\u201389."},{"key":"BF1300021_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-349-09927-6_4","volume-title":"Peptide and Amino Acid Transport Mechanisms in the Central Nervous System","author":"A Ermisch","year":"1988","unstructured":"Ermisch A, Landgraf R, Brust P, Kretzschmar R, Hess J (1988). Peptide receptors of the cerebral capillary endothelium and the transport of amino acids across the blood\u2013brain barrier. In: Rakic L, Begley DJ, Davson H, Zlokovic BV (eds). Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Stockton Press: New York, pp 41\u201353."},{"key":"BF1300021_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.1993.73.3.489","volume":"73","author":"A Ermisch","year":"1993","unstructured":"Ermisch A, Brust P, Kretzchmar R, Ruhle H-J (1993). Peptides and the blood\u2013brain barrier. Physiol Rev 73: 489\u2013527.","journal-title":"Physiol Rev"},{"key":"BF1300021_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/77040","volume":"25","author":"JN Ferguson","year":"2000","unstructured":"Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT (2000). Social amnesia in mice lacking the oxytocin gene. Nat Genet 25: 284\u2013288.","journal-title":"Nat Genet"},{"key":"BF1300021_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0006-3223(01)01139-8","volume":"50","author":"LA Green","year":"2001","unstructured":"Green LA, Fein D, Modahl C, Feinstein C, Waterhouse L, Morris M (2001). Oxytocin and autistic disorder: alteration in peptide forms. Biol Psychiatry 50: 609\u2013613.","journal-title":"Biol Psychiatry"},{"key":"BF1300021_CR22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/ajp.156.2.317","volume":"156","author":"E Hollander","year":"1999","unstructured":"Hollander E, DelGiudice-Asch G, Simon L, Schmeidler J, Cartwright C, DeCaria CM et al (1999). B lymphocyte antigen D8\/17 and repetitive behaviors in autism. Am J Psychiatry 156: 317\u2013320.","journal-title":"Am J Psychiatry"},{"key":"BF1300021_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0893-133X(99)00121-9","volume":"22","author":"E Hollander","year":"2000","unstructured":"Hollander E, Novotny S, Allen A, Aronowitz B, Cartwright C, DeCaria C (2000). The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology 22: 163\u2013167.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300021_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1037\/0735-7044.109.4.782","volume":"109","author":"TR Insel","year":"1995","unstructured":"Insel TR, Hulihan TJ (1995). A gender-specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles. Behav Neurosci 109: 782\u2013789.","journal-title":"Behav Neurosci"},{"key":"BF1300021_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0006-3223(98)00142-5","volume":"45","author":"TR Insel","year":"1999","unstructured":"Insel TR, O\u2019Brien DJ, Leckman JF (1999). Oxytocin, vasopressin, and autism: is there a connection. Biol. Psychiatry 45: 145\u2013157.","journal-title":"Biol. Psychiatry"},{"key":"BF1300021_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0014-2999(91)90806-2","volume":"203","author":"TR Insel","year":"1991","unstructured":"Insel TR, Winslow JT (1991). Central administration of oxytocin modulates the infant rat's response to social isolation. Eur J Pharmacol. 203: 149\u2013152.","journal-title":"Eur J Pharmacol."},{"key":"BF1300021_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0006-3223(98)00094-8","volume":"443","author":"TR Insel","year":"1998","unstructured":"Insel TR, Winslow JT (1998). Serotonin and neuropeptides in affiliative behaviors. Biol Psychiatry 443: 207\u2013219.","journal-title":"Biol Psychiatry"},{"key":"BF1300021_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/35053579","volume":"2","author":"TR Insel","year":"2001","unstructured":"Insel TR, Young LJ (2001). The neurobiology of attachment. Nature Reviews Neuroscience 2: 129\u2013136.","journal-title":"Nature Reviews Neuroscience"},{"key":"BF1300021_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1210\/endo-128-2-891","volume":"128","author":"AE Johnson","year":"1990","unstructured":"Johnson AE, Coirini H, Insel TR, McEwen BS (1990). The regulation of oxytocin receptor binding in the ventromedial hypothalamic nucleus by testosterone and its metabolites. Endocrinology 128: 891\u2013896.","journal-title":"Endocrinology"},{"key":"BF1300021_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0006-8993(86)90229-5","volume":"380","author":"R Kretzchmar","year":"1986","unstructured":"Kretzchmar R, Landgraf R, Gjedde A, Ermisch A (1986). Vasopressin binds to microvessels from rat hippocampus. Brain Res 380: 325\u2013330.","journal-title":"Brain Res"},{"key":"BF1300021_CR31","first-page":"45","volume":"70","author":"R Landgraf","year":"1977","unstructured":"Landgraf R, Hess J, Hartmann E (1977). Effect of oxytocin on regional 3H-orotic acid uptake in rat brain. Endokrinologie 70: 45\u201352.","journal-title":"Endokrinologie"},{"key":"BF1300021_CR32","first-page":"655","volume":"37","author":"R Landgraf","year":"1978","unstructured":"Landgraf R, Hess J, Ermisch A (1978). The influence of vasopressin on the regional uptake of [3H] orotic acid by the rat brain. Acta Biol Med Ger 37: 655\u2013658.","journal-title":"Acta Biol Med Ger"},{"key":"BF1300021_CR33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/archpsyc.1994.03950100030003","volume":"51","author":"JF Leckman","year":"1994","unstructured":"Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL et al (1994). Elevated cerebrospinal fluid levels of oxytocin in obsessive\u2013compulsive disorder Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry 51: 782\u2013792.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300021_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter M, LeCouteur A (1994). Autism Diagnostic Interview-Revised: a revised version of a diagnostic scale for caregivers of individuals with possible pervasive developmental disorders. J Autism Develop Disorders 24: 659\u2013685.","journal-title":"J Autism Develop Disorders"},{"key":"BF1300021_CR35","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/S0006-3223(98)00190-5","volume":"44","author":"A Martin","year":"1998","unstructured":"Martin A, State M, Anderson GM, Kaye WM, Hanchett JM, McConaha CW et al (1998). Cerebrospinal fluid levels of oxytocin in Prader\u2013Willi syndrome: a preliminary report. Biol Psychiatry 44: 1349\u20131352.","journal-title":"Biol Psychiatry"},{"key":"BF1300021_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0149-7634(83)90019-2","volume":"7","author":"G Meisenberg","year":"1983","unstructured":"Meisenberg G, Simmons WH (1983a). Centrally mediated effects of neurohypophyseal hormones. Neurosci Biobehav Rev 7: 263\u2013280.","journal-title":"Neurosci Biobehav Rev"},{"key":"BF1300021_CR37","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/0024-3205(83)90352-1","volume":"32","author":"G Meisenberg","year":"1983","unstructured":"Meisenberg G, Simmons WH (1983b). Peptides and the blood\u2013brain barrier. Life Sci 32: 2611\u20132623.","journal-title":"Life Sci"},{"key":"BF1300021_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0006-3223(97)00439-3","volume":"43","author":"C Modahl","year":"1998","unstructured":"Modahl C, Green L, Fein D, Morris M, Waterhouse L, Feinstein C, Levin H (1998). Plasma oxytocin levels in autistic children. Biol Psychiatry 43: 270\u2013277.","journal-title":"Biol Psychiatry"},{"key":"BF1300021_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1749-6632.1997.tb51963.x","volume":"807","author":"E Nelson","year":"1997","unstructured":"Nelson E, Alberts JR (1997). Oxytocin-induced paw sucking in infant rats. Ann NY Acad Sci 807: 543\u2013545.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300021_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1037\/0735-7044.110.3.583","volume":"110","author":"E Nelson","year":"1996","unstructured":"Nelson E, Panksepp J (1996). Oxytocin mediates acquisition of maternally associated odor preferences in preweanling rat pups. Behav Neurosci 110: 583\u2013592.","journal-title":"Behav Neurosci"},{"key":"BF1300021_CR41","doi-asserted-by":"publisher","first-page":"11699","DOI":"10.1073\/pnas.93.21.11699","volume":"93","author":"K Nishimori","year":"1996","unstructured":"Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR, Matzuk MM (1996). Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Nat Acad Sci USA 93: 11699\u201311704.","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF1300021_CR42","first-page":"243","volume-title":"Oxytocin in Maternal Sexual and Social Processes","author":"J Panksepp","year":"1992","unstructured":"Panksepp J (1992). Oxytocin effects on emotional processes: separation distress, social bonding, and relationships to psychiatric disorders. In: Pedersen C, Caldwell J, Jirikowski G, Insel T (eds). Oxytocin in Maternal Sexual and Social Processes. Vol 652. New York Academy of Sciences, New York, 243\u2013252."},{"key":"BF1300021_CR43","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0024-3205(92)90368-Y","volume":"50","author":"P Popik","year":"1992","unstructured":"Popik P, Van Ree JM (1992). Long term facilitation of social recognition in rats by vasopressin related peptides: a structure\u2013activity study. Life Sci 50: 567\u2013572.","journal-title":"Life Sci"},{"key":"BF1300021_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF02253591","volume":"106","author":"P Popik","year":"1992","unstructured":"Popik P, Vetulani J, van Ree JM (1992a). Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology 106: 71\u201374.","journal-title":"Psychopharmacology"},{"key":"BF1300021_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/00008877-199208000-00011","volume":"3","author":"P Popik","year":"1992","unstructured":"Popik P, Vos P, van Ree J (1992b). Neurohypophyseal hormone receptors in the septum are implicated in social recognition in the rat. Behav Pharmacol 3: 351\u2013358.","journal-title":"Behav Pharmacol"},{"key":"BF1300021_CR46","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/0091-3057(79)90334-4","volume":"10","author":"TC Rainbow","year":"1979","unstructured":"Rainbow TC, Flexner JB, Flexner LB, Hoffman PL, Walter R (1979). Distribution, survival and biological effects in mice of a behaviorally active, enzymatically stable peptide: pharmacokinetics of cyclo-(Leu-Gly) and puromycin-induced amnesia. Pharmacol Biochem Behav 10: 787\u2013793.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300021_CR47","first-page":"713","volume":"149","author":"AD Salzberg","year":"1992","unstructured":"Salzberg AD, Swedo SE (1992). Oxytocin and vasopressin in obsessive\u2013compulsive disorder. Am J Psychiatry 149: 713\u2013714.","journal-title":"Am J Psychiatry"},{"key":"BF1300021_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/syn.890040312","volume":"4","author":"LE Shapiro","year":"1989","unstructured":"Shapiro LE, Insel TR (1989). Ontogeny of oxytocin receptors in rat forebrain: a quantitative study. Synapse 4: 259\u2013266.","journal-title":"Synapse"},{"key":"BF1300021_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archpsyc.1992.01820010029004","volume":"49","author":"SE Swedo","year":"1992","unstructured":"Swedo SE, Leonard HL, Kruesi MJ, Rettew DC, Listwak SJ, Berrettini W et al (1992). Cerebrospinal fluid neurochemistry in children and adolescents with obsessive\u2013compulsive disorder. Arch Gen Psychiatry 49: 29\u201336.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300021_CR50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0091-3057(96)00346-2","volume":"57","author":"S Tanabe","year":"1997","unstructured":"Tanabe S, Shishido Y, Furushiro M, Kado K, Hashimoto S, Yokokura T, Ohsawa T (1997). Facilitation of passive avoid-ance response by newly synthesized cationized arginine vasopressin fragment 4\u20139 in rats. Pharmacol Biochem Behav 57: 251\u2013256.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300021_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(90)90334-3","volume":"187","author":"TB van Wimersma Greidanus","year":"1990","unstructured":"van Wimersma Greidanus TB, Kroodsma JM, Pot MLH, Stevens M, Maigret C (1990). Neurohypophyseal hormones and excessive grooming behavior. Eur J Pharmacol 187: 1\u20138.","journal-title":"Eur J Pharmacol"},{"key":"BF1300021_CR52","doi-asserted-by":"crossref","unstructured":"Walter R, Hoffman PL, Flexner JB, Flexner LB (1975). Proc Nat Acad Sci USA 72: 4180\u20134184.","DOI":"10.1073\/pnas.72.10.4180"},{"key":"BF1300021_CR53","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1523\/JNEUROSCI.11-07-02032.1991","volume":"11","author":"DM Winslow","year":"1991","unstructured":"Winslow DM, Insel TR (1991). Social status in the pairs of male squirrel monkeys determines the behavioral response to central oxytocin administration. J Neurosci 11: 2032\u20132038.","journal-title":"J Neurosci"},{"key":"BF1300021_CR54","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/365545a0","volume":"365","author":"JT Winslow","year":"1993","unstructured":"Winslow JT, Hastings N, Carter CS, Harbaugh CR, Insel TR (1993). A role for central vasopressin in pair bonding in monogamous prairie voles. Nature 365: 545\u2013548.","journal-title":"Nature"},{"key":"BF1300021_CR55","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0091-3057(92)90418-F","volume":"43","author":"DM Witt","year":"1992","unstructured":"Witt DM, Winslow JT, Insel TR (1992). Enhanced social interactions in rats following chronic, centrally infused oxytocin. Pharmacol, Biochem Behav 43: 855\u2013861.","journal-title":"Pharmacol, Biochem Behav"},{"key":"BF1300021_CR56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/hbeh.1997.1377","volume":"31","author":"LJ Young","year":"1997","unstructured":"Young LJ, Winslow JT, Wang Z, Gingrich B, Guo Q, Matzuk MM et al (1997). Gene targeting approaches to neuroendocrinology: oxytocin, maternal behavior, and affiliation. Hormones Behav 31: 221\u2013231.","journal-title":"Hormones Behav"},{"key":"BF1300021_CR57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0005-2736(90)90097-8","volume":"1025","author":"BV Zlokovic","year":"1990","unstructured":"Zlokovic BV, Hyman S, McComb JG, Lipovac MN, Tang G, Davson H (1990). Kinetics of arginine-vasopressin uptake at the blood\u2013brain barrier. Biochim Biophys Acta 1025: 191\u2013198.","journal-title":"Biochim Biophys Acta"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300021","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:44:00Z","timestamp":1684223040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["BF1300021"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300021","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}